Skip to main content
. 2011 Aug 24;6(8):e23968. doi: 10.1371/journal.pone.0023968

Figure 3. Time course of disease progression in SOD1G93A mice monitored with three different tests.

Figure 3

(A) Motor signs (hind limb tremors) were measured with the clinical scoring system (see methods). (B) Body weight was monitored twice a week. (C) The number of ChAT-positive cell bodies was decreased at end-stage disease for SOD1G93A mice. **p<0.01 vs. wild-type mice. Data represent mean ± SEM.